Ever since artificial intelligence (AI) drug developer Xaira Therapeutics launched in April 2024 with a jaw-dropping $1 billion in committed capital and a star-studded leadership lineup—including ...

The FDA plans to include aging and longevity among topics in the updated Focus Areas of Regulatory Science (FARS) report it plans to issue in federal FY 2027.

Results could provide insights into strategies for reducing anxiety symptoms in other contexts, outside of cannabis use.

Nektar Therapeutics won its legal dispute with Eli Lilly over rezpegaldesleukin, but the court victory failed to deliver a ...

Internal benchmarks show that Ptarmigan-1 can run 5,000x faster than structure-based methods and screen over three billion compounds in a day.

Consortium members are expected to have access to the dataset by early 2027, and there are plans to add more complex antibody ...

Researchers at Washington University School of Medicine in St. Louis have developed a potential antibody-based approach to ...

Merck acquires global rights to SciBrunch Therapeutics’ SPR2015, a preclinical oral KRAS G12D inhibitor, in a deal worth up ...

Most screening readouts are snapshots. An endpoint measurement can obscure differences in association rate and dissociation ...

The findings by scientists at NYU Abu Dhabi provide new insight into how cells respond when cancer-causing genes are ...

A slow-release liposome system delivered local anesthesia for weeks in rats, potentially enabling new approaches to pain ...

Researchers at the Nano Life Science Institute at Kanazawa University in Japan say they have directly visualized how enzymes ...